Medical Oncology

Jeffrey Melson Clarke, MD

Assistant Professor of Medicine
Member of the Duke Cancer Institute
Campus mail Dept Of Medicine, Box_31379 Med Ctr, Durham, NC 27710
Phone (919) 684-8111
Email address jeffrey.clarke@duke.edu
In Their Words

Education and Training

  • Internal Medicine Chief Resident, Medicine, Duke University School of Medicine, 2012 - 2013
  • Hematology and Medical Oncology Fellowship, Medicine, Duke University School of Medicine, 2011 - 2015
  • Categorical Internal Medicine Residency, Medicine, Duke University School of Medicine, 2008 - 2011
  • M.D., Indiana University School of Medicine, 2008

Grants

Publications

Shariff, AI, Syed, S, Shelby, RA, Force, J, Clarke, JM, D'Alessio, D, and Corsino, L. "Novel cancer therapies and their association with diabetes." Journal of Molecular Endocrinology 62, no. 2 (February 2019): R187-R199. (Review)

PMID
30532995
Full Text

Pabla, S, Conroy, JM, Nesline, MK, Glenn, ST, Papanicolau-Sengos, A, Burgher, B, Hagen, J, Giamo, V, Andreas, J, Lenzo, FL, Yirong, W, Dy, GK, Yau, E, Early, A, Chen, H, Bshara, W, Madden, KG, Shirai, K, Dragnev, K, Tafe, LJ, Marin, D, Zhu, J, Clarke, J, Labriola, M, McCall, S, Zhang, T, Zibelman, M, Ghatalia, P, Araujo-Fernandez, I, Singavi, A, George, B, MacKinnon, AC, Thompson, J, Singh, R, Jacob, R, Dressler, L, Steciuk, M, Binns, O, Kasuganti, D, Shah, N, Ernstoff, M, Odunsi, K, Kurzrock, R, Gardner, M, Galluzzi, L, and Morrison, C. "Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients." Journal for Immunotherapy of Cancer 7, no. 1 (February 2019): 27-null.

PMID
30709424
Full Text

Conroy, JM, Pabla, S, Nesline, MK, Glenn, ST, Papanicolau-Sengos, A, Burgher, B, Andreas, J, Giamo, V, Wang, Y, Lenzo, FL, Bshara, W, Khalil, M, Dy, GK, Madden, KG, Shirai, K, Dragnev, K, Tafe, LJ, Zhu, J, Labriola, M, Marin, D, McCall, SJ, Clarke, J, George, DJ, Zhang, T, Zibelman, M, Ghatalia, P, Araujo-Fernandez, I, de la Cruz-Merino, L, Singavi, A, George, B, MacKinnon, AC, Thompson, J, Singh, R, Jacob, R, Kasuganti, D, Shah, N, Day, R, Galluzzi, L, Gardner, M, and Morrison, C. "Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors." Journal for Immunotherapy of Cancer 7, no. 1 (January 24, 2019): 18-null.

PMID
30678715
Full Text

Velikova, G, Williams, LJ, Willis, S, Dixon, JM, Loncaster, J, Hatton, M, Clarke, J, Kunkler, IH, Russell, NS, Alhasso, A, Adamson, D, Algurafi, H, Allerton, R, Anandadas, C, Bahl, A, Barraclough, L, Barrett-Lee, P, Barthakur, U, Bedi, C, Beresford, M, Bishop, J, Blackman, G, Bliss, P, Bloomfield, D, Blunt, M, Branson, T, Brazil, L, Brunt, A, Chakrabarti, A, Chittalie, A, Churn, M, Clarke, J, Cleator, S, Crellin, P, Danwata, F, De-Silva-Minor, S, Dhadda, A, Eicholz, A, Fernando, I, Forrest, J, Fraser, J, Geropantas, K, Goodman, A, Grieve, R, Griffin, M, Hadaki, M, Hall, A, Hatton, M, Hicks, J, Hignett, S, Hogg, M, Jyothirmayi, R, Khan, M, Kumar, S, Lawton, P, Lee, D, Lewinski, C, Lim, C, Locke, I, Loncaster, J, Lumsden, G, Lupton, S, Magee, B, Marshall, J, Masinghe, S, McGregor, C, McLennan, M, Memtsa, P, Milanovic, D, Misra, V, Mithal, N, Mukesh, MB, Neal, A, Needleman, S, Persic, M, Quigley, M, Raj, S, Riddle, P, Ritchie, D, Roberts, F, Robson, P, Roe, H, Rolles, M, Shah, N, Sharma, R, Sherwin, E, Simmonds, P, Skailles, G, Skaria, S, Soe, W, Sripadam, R, Stevens, A, Stockdale, A, Storey, N, Syndikus, I, Thorp, N, Upadhyay, S, Varughese, M, Walji, N, Welch, R, Wells, T, Wolstenholme, V, Woodings, P, and Yuille, F. "Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial." The Lancet Oncology 19, no. 11 (November 2018): 1516-1529.

Full Text

Marano, AL, Clarke, JM, Morse, MA, Shah, A, Barrow, W, Selim, MA, Hall, RP, and Cardones, AR. "Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy." The British Journal of Dermatology (September 23, 2018).

PMID
30244487
Full Text

DeMaio, A, Clarke, JM, Dash, R, Sebastian, S, Wahidi, MM, Shofer, SL, Cheng, GZ, Li, X, Wang, X, and Mahmood, K. "Yield of Malignant Pleural Effusion for Detection of Oncogenic Driver Mutations in Lung Adenocarcinoma." Journal of Bronchology & Interventional Pulmonology (July 25, 2018).

PMID
30048416
Full Text

Clarke, JM, George, DJ, Lisi, S, and Salama, AKS. "Immune Checkpoint Blockade: The New Frontier in Cancer Treatment." Targeted oncology 13, no. 1 (February 13, 2018): 1-20.

PMID
29441437
Full Text

Yi, JS, Ready, N, Healy, P, Dumbauld, C, Osborne, R, Berry, M, Shoemaker, D, Clarke, J, Crawford, J, Tong, B, Harpole, D, D'Amico, TA, McSherry, F, Dunphy, F, McCall, SJ, Christensen, JD, Wang, X, and Weinhold, KJ. "Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 23, no. 24 (December 2017): 7474-7482.

PMID
28951518
Full Text

Bedoya, A, Glisinski, K, Clarke, J, Lind, RN, Buckley, CE, and Shofer, S. "Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two Cases." The American Journal of Case Reports 18 (July 31, 2017): 842-846.

PMID
28757601
Full Text

Clarke, JM, Wang, X, and Ready, NE. "Surrogate clinical endpoints to predict overall survival in non-small cell lung cancer trials-are we in a new era?." Translational Lung Cancer Research 4, no. 6 (December 2015): 804-808.

PMID
26798592
Full Text

Pages